MCRI Provides Funding for Novel Multiple Myeloma Research
The first patient-led crowdfunding initiative for research in multiple myeloma has raised more than $500,000 to explore new treatments for high-risk patients. The Myeloma Crowd Research Initiative (MCRI) is a novel approach to identifying and funding cancer research; it joins myeloma specialists with patient advocates and community leaders.
The MCRI is led by Myeloma Crowd, a division of the CrowdCare Foundation, which is a patient-driven, nonprofit organization. The MCRI received 36 research proposals from investigators worldwide and assembled a list of the top 10.
The first two projects selected for funding are a study of chimeric antigen receptor T-cell therapy targeting CS1 and BCMA, led by Hermann Einsele, MD, and Michael Hudecek, MD, both of the University of Würzburg, Germany, and a study of T-cell therapy with autologous transplant, led by Ivan Borrello, MD, of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.